NovaBay Pharmaceuticals, Inc.·4/A

Oct 28, 4:29 PM ET

Hall Justin 4/A

4/A · NovaBay Pharmaceuticals, Inc. · Filed Oct 28, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2019-06-10
Hall Justin
General Counsel
Transactions
  • Award

    Common Stock

    2019-06-10$2.02/sh+47,500$95,95050,905 total
  • Sale

    Common Stock

    2019-06-10$3.03/sh47,500$143,9253,405 total
  • Exercise of In-Money

    Stock Option (right to buy)

    2019-06-1047,5000 total
    Exercise: $2.02From: 2019-05-31Exp: 2028-05-31Common Stock (47,500 underlying)
Footnotes (1)
  • [F1]The amended Form 4 is being filed to show (1) the corresponding acquisition of common stock after the exercise of options in Table I and (2) the immediate sale of common stock after such exercise of options in Table I.

Documents

1 file
  • 4
    rdgdoc.xml

    FORM 4/A